Perioperative vs Postoperative Chemotherapy + Bevacizumab in Colorectal Cancer, Liver Mets

NCT01632722 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

79

Enrollment

OTHER

Sponsor class

Conditions

Colorectal Cancer
Liver Metastasis

Interventions

DRUG: Bevacizumab, mFOLFOX, FOLFIRI
DRUG: Bevacizumab, mFOLFOX, FOLFIRI

Sponsor

Yonsei University